drugset / Trial / NCT01111994
Efficacy & Safety of Clindamycin and Tretinoin in Acne
Phase 4
Unknown
30 enrolled
Callender Center for Clinical Research
Society Hill Dermatology · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is ascertain the efficacy and safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post Inflammatory Hyperpigmentation in patients with skin of color.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clindamycin | Unknown | 1.2 % | Topical |
| Subject | Tretinoin | Small molecule | 0.025 % | Topical |